Skip to Main Content

Author Details

Nilanjana Maulik
University of Connecticut Health
1992
222
64
PMIDPaper TitleJournal TitlePublished Year
37778482Novel approaches to determine the functional role of cardiomyocyte specific E3 ligase, Pellino-1 following myocardial infarction.Biochim Biophys Acta Mol Basis Dis2024
36114673Driving adult tissue repair via re-engagement of a pathway required for fetal healing.Mol Ther2023
37296648Role of Pellino-1 in Inflammation and Cardioprotection following Severe Sepsis: A Novel Mechanism in a Murine Severe Sepsis Model <sup>â¿ </sup>.Cells2023
34999110Gene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model.Microvasc Res2022
35758926Protective Effect of Cardiomyocyte-Specific Prolyl-4-Hydroxylase 2 Inhibition on Ischemic Injury in a Mouse MI Model.J Am Coll Surg2022
34092373Heat shock protein A12B gene therapy improves perfusion, promotes neovascularization, and decreases fibrosis in a murine model of hind limb ischemia.Surgery2021
33539996Engineered resveratrol-loaded fibrous scaffolds promotes functional cardiac repair and regeneration through Thioredoxin-1 mediated VEGF pathway.Int J Pharm2021
32537701Deletion of newly described pro-survival molecule Pellino-1 increases oxidative stress, downregulates cIAP2/NF-κB cell survival pathway, reduces angiogenic response, and thereby aggravates tissue function in mouse ischemic models.Basic Res Cardiol2020
30639221Evaluation of dermal tissue regeneration using resveratrol loaded fibrous matrix in a preclinical mouse model of full-thickness ischemic wound.Int J Pharm2019
31045571Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.J Clin Invest2019
30971427Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells.J Biol Chem2019
28950048Development of next generation cardiovascular therapeutics through bio-assisted nanotechnology.J Biomed Mater Res B Appl Biomater2018
30131176Thioredoxin-1 augments wound healing and promote angiogenesis in a murine ischemic full-thickness wound model.Surgery2018
30136862Graphene-based drug delivery systems in tissue engineering and nanomedicine.Can J Physiol Pharmacol2018
30371196Disruption of VEGF Mediated Flk-1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino-1.J Am Heart Assoc2018
28807201Overexpression of Thioredoxin1 enhances functional recovery in a mouse model of hind limb ischemia.J Surg Res2017
28281242Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.J Cardiovasc Transl Res2017
28407473Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Can J Physiol Pharmacol2017
28177171Increased survivability of ischemic skin flap tissue in Flk-1<sup>+/-</sup> mice by Pellino-1 intervention.Microcirculation2017
29180214Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice.J Surg Res2017
26808992Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction".Int J Cardiol2016
25446011Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.Microvasc Res2015
26322599Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.Int J Cardiol2015
26342597Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.J Physiol Biochem2015
26417924Thioredoxins in cardiovascular disease.Can J Physiol Pharmacol2015
26078815Antioxidants in Longevity and Medicine 2014.Oxid Med Cell Longev2015
25882068Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.Arterioscler Thromb Vasc Biol2015
23978105Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.Curr Pharm Des2014
24307101Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.Mol Cell Biochem2014
23992027Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.Antioxid Redox Signal2014
21960420Cardioprotective efficacy of a novel antioxidant mix VitaePro against ex vivo myocardial ischemia-reperfusion injury.Cell Biochem Biophys2013
24327827Antioxidants in longevity and medicine.Oxid Med Cell Longev2013
23590933Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.Int J Cardiol2013
21942294Curcumin heals indomethacin-induced gastric ulceration by stimulation of angiogenesis and restitution of collagen fibers via VEGF and MMP-2 mediated signaling.Antioxid Redox Signal2012
22812658Nutrition and the healthy heart with an exercise boost.Can J Physiol Pharmacol2012
22523530Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.PLoS One2012
22229755Epigenetic manifestation of metabolic syndrome and dietary management.Antioxid Redox Signal2012
22424133HIF-prolyl hydroxylases and cardiovascular diseases.Toxicol Mech Methods2012
22394340Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview.Toxicol Mech Methods2012
22339352Factors influencing epigenetic mechanisms and related diseases.Antioxid Redox Signal2012
22038056Novel role of NADPH oxidase in ischemic myocardium: a study with Nox2 knockout mice.Funct Integr Genomics2012
21074540Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.J Mol Cell Cardiol2011
21395498Risk factors in heart disease: therapeutic interventions.Antioxid Redox Signal2011
21083501Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.Antioxid Redox Signal2011
19794062Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Diabetes2010
20538586Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.J Biol Chem2010
20194885Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.Circulation2010
20213262Comparative effects of a novel plant-based calcium supplement with two common calcium salts on proliferation and mineralization in human osteoblast cells.Mol Cell Biochem2010
20421635Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.Am J Physiol Regul Integr Comp Physiol2010
19027847Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury.Biochim Biophys Acta2009
  • 1 - 50 of 222

Recommended Authors

Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Career Start Year 2011
Number of shared co-authors 0
The First Affiliated Hospital of Zhengzhou University
Career Start Year 2009
Number of shared co-authors 0
Renmin Hospital of Wuhan University
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 2003
Number of shared co-authors 0
University Medical Centers
Career Start Year 2002
Number of shared co-authors 0
Molecular Cardiology Research Institute, Tufts Medical Center
Career Start Year 2002
Number of shared co-authors 0
University of California davis
Career Start Year 2001
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Career Start Year 1999
Number of shared co-authors 0
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1999
Number of shared co-authors 0
Tri-Service General Hospital, National Defense Medical Center
Career Start Year 1998
Number of shared co-authors 0
Baker Heart and Diabetes Institute
Career Start Year 1998
Number of shared co-authors 0
Vanderbilt University Medical Center, 1211 Medical Center Drive
Career Start Year 1997
Number of shared co-authors 0
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
Medical College of Georgia, Augusta University
Career Start Year 1993
Number of shared co-authors 0
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 0
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
University of New South Wales
Career Start Year 1991
Number of shared co-authors 1
University Medical Centers
Career Start Year 1991
Number of shared co-authors 0
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1989
Number of shared co-authors 0
University of Science and Technology of China
Career Start Year 1987
Number of shared co-authors 0
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 0
The William Harvey Research Institute, Queen Mary University of London
Career Start Year 1984
Number of shared co-authors 0
and Blood Institute
Career Start Year 1983
Number of shared co-authors 0
Beth Israel Deaconess Medical Center.
Career Start Year 1983
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 0
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 0
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 0

Collaborators

S.N. Bose National Centre for Basic Sciences
Co-authored papers 121
University of Massachusetts Medical School-Baystate
Co-authored papers 46
University of Connecticut School of Medicine
Co-authored papers 25
Kansai Medical University
Co-authored papers 25
Baystate Medical Center
Co-authored papers 17
Baystate Medical Center
Co-authored papers 13
Baystate Medical Center
Co-authored papers 13
University of Massachusetts Medical School-Baystate
Co-authored papers 12
Hokushin General Hospital
Co-authored papers 12
Hiroshima University Hospital
Co-authored papers 11
Cardiovascular Research Center, University of Connecticut School of Medicine
Co-authored papers 9
University of Connecticut School of Medicine
Co-authored papers 6
Center for Free Radical and Antioxidant Health, University of Pittsburgh
Co-authored papers 5
Co-authored papers 4
University of Connecticut Health Center
Co-authored papers 4
Institute of Neurobiology, Bulgarian Academy of Sciences
Co-authored papers 3
School of Medicine. University of Connecticut
Co-authored papers 2
Co-authored papers 2
Armed Forces Radiobiology Research Institute
Co-authored papers 1
University of Connecticut School of Medicine
Co-authored papers 1
Institute for Global Food Security, Queen's University Belfast
Co-authored papers 1
Co-authored papers 1
School of Public Health, Imperial College London
Co-authored papers 1
SUNY Down State Medical Center
Co-authored papers 1
Erasmus Medical Center
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Affiliated Tumor Hospital of Guangxi Medical University
Co-authored papers 1
Co-authored papers 1